Sponsors & Exhibitors

About Roche in Aotearoa New Zealand
For more than 125 years, Roche has been committed to improving lives. Headquartered in Basel, Switzerland, Roche continues to search for better ways to prevent, diagnose, and treat diseases and make a sustainable contribution to society. We have had a presence in Aotearoa New Zealand since 1973 and operate across two key businesses - diagnostics and pharmaceuticals..

Roche Diagnostics is a leading supplier of diagnostic solutions covering a broad spectrum of medical conditions, including neurology, cardiometabolic disease, infectious disease, oncology, and women's health. In 2023, over 29 billion tests were performed globally using one of our solutions.

Roche Pharmaceuticals delivers differentiated medicines across a broad range of therapeutic areas, including oncology/haematology, immunology, infectious diseases, cardiovascular, renal, metabolism, ophthalmology, and central nervous system diseases. Thirty-two medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them antibiotics, anti-malarials, and chemotherapy.

Across the two Aotearoa New Zealand businesses, almost 100 employees strive towards one purpose: to do now what patients need next.

CSL Limited is an Australian multinational specialty biotechnology company with focus across R&D, manufacturing and marketing of innovative and life-saving medicines for the prevention and treatment of serious conditions.

CSL Behring is the world’s largest collector of human plasma and the chosen national plasma fractionator of New Zealand since 1962. Today CSL Behring partners with the New Zealand Blood Service and health care professionals to deliver a broad range of plasma products, including intravenous and subcutaneous immunoglobulin.

CSL Seqirus manufactures and markets vaccines and pharmaceutical products for New Zealand. CSL Seqirus also in-licenses products from partner companies for a variety of specialties including Neurology (epilepsy), ensuring a comprehensive range of products are available for New Zealanders.

Eisai (pronounced ‘ā-zī’) is derived from the Japanese word for ‘health product’ and, here at Eisai, we discover, develop and market innovative, high-quality medicines throughout the world.

We place primary emphasis on patients and their families, and observe the highest legal and ethical standards in our business activities.

Eisai is one of the world’s leading research-based pharmaceutical companies.

We define our corporate mission as “giving first thought to patients and their families, and to increasing the benefits health care provides,” which we call human health care (hhc). With operations in the U.S., Asia, Europe and its domestic home market of Japan, Eisai employs more than 11,000 people worldwide.

Eisai focuses its efforts in several therapeutic areas and in New Zealand, Neurology and Oncology are our primary specialty areas.

For more information about Eisai, or our products, please visit our website or email Contact_NewZealand@eisai.net

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio.

For more information about AbbVie, please visit our website. Follow on Facebook or our LinkedIn page.

Ipsen provides specialty medicines and quality services to Healthcare Professionals and their patients suffering from debilitating diseases.

At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals. We deliver tailored solutions through our agility and innovation and we strive to be even better tomorrow than we are today.

Ipsen Pty Ltd is the Australian affiliate of a global R & D focused pharmaceutical company.